Rhino-orbito-cerebral mucormycosis caused by Rhizopus microsporus var. microsporus in a diabetic patient with COVID-19

AUTOR(ES)

Munhoz, Sandy Daniele; Lellis, Rute Facchini; Reis, Ana Paula Carvalho; Negro, Gilda Maria Barbaro Del; Sousa, Maria Glória Teixeira; Veasey, John Verrinder

FONTE

Anais Brasileiros de Dermatologia

DATA DE PUBLICAÇÃO

2022

RESUMO

Abstract COVID-19 disease caused by the SARS-CoV-2 coronavirus causes a wide range of clinical manifestations, ranging from mild to severe, with the main ones affecting the respiratory tract, such as pneumonia. In patients with greater severity, the high frequency of bacterial and fungal coinfection stands out, a situation related both to the patient’s pre-existing comorbidities and due to the hospitalization itself. Cases of mucormycosis associated with COVID-19 were highlighted in the lay and scientific media, with the increase in mycosis cases being directly and indirectly attributed to the viral infection. This report describes a case of rhino-orbito-cerebral mucormycosis in a diabetic patient hospitalized for COVID-19, whose diagnosis was confirmed by identifying the agent Rhizopus microsporus var. microsporus through culture for fungi and PCR examination.

Documentos Relacionados

• Refractory rhino-orbito-cerebral mucormycosis treated with intraconal amphotericin B
• Mucormycosis caused by Rhizopus microsporus var. microsporus: cellulitis in the leg of a diabetic patient cured by amputation.
• Biotechnological potential of alternative carbon sources for production of pectinases by Rhizopus microsporus var. rhizopodiformis
• Wooden sticks as the source of a pseudoepidemic of infection with Rhizopus microsporus var. rhizopodiformis among immunocompromised patients.
• Produção e caracterização de uma [beta]-glicanase de Rhizopus microsporus var. microsporus, e seu potencial para aplicação na indústria da cerveja